Cargando…
The Bruton tyrosine kinase inhibitor ibrutinib improves anti-MAG antibody polyneuropathy
OBJECTIVE: To assess whether neuropathy with anti-myelin-associated glycoprotein (MAG) antibody may improve after treatment with ibrutinib, an oral inhibitor of Bruton tyrosine kinase, we prospectively treated with ibrutinib a cohort of 3 patients with anti-MAG neuropathy and Waldenström macroglobul...
Autores principales: | Castellani, Francesca, Visentin, Andrea, Campagnolo, Marta, Salvalaggio, Alessandro, Cacciavillani, Mario, Candiotto, Cinzia, Bertorelle, Roberta, Trentin, Livio, Briani, Chiara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176252/ https://www.ncbi.nlm.nih.gov/pubmed/32284437 http://dx.doi.org/10.1212/NXI.0000000000000720 |
Ejemplares similares
-
The BCL2 Inhibitor Venetoclax Plus Rituximab Is Active in MYD88 Wild-Type Polyneuropathy With Anti-MAG Antibodies
por: Briani, Chiara, et al.
Publicado: (2022) -
Mutational Profile in 75 Patients With Anti–Myelin-Associated Glycoprotein Neuropathy: Clinical and Hematologic Therapy Response and Hints on New Therapeutic Targets
por: Castellani, Francesca, et al.
Publicado: (2023) -
Indirect effects of the lockdown for the COVID-19 pandemic: Comparative study of fibular palsies from prolonged sitting posture
por: Castellani, F., et al.
Publicado: (2021) -
Vasculitic flare in a patient with anti-myelin-associated glycoprotein (MAG) antibody following mRNA-1273 SARS-CoV-2 vaccine
por: Briani, Chiara, et al.
Publicado: (2022) -
The Bruton’s Tyrosine Kinase Inhibitor Ibrutinib Impairs the Vascular Development of Zebrafish Larvae
por: Wang, Kun, et al.
Publicado: (2021)